Fremont, Ca., USA - July 14, 2015, Fremont, Ca., USA - Zosano Pharma Corporation announced the hiring of Donald Kellerman, David Zhang and Jacquie Mardell.
Article continues below
Zosano elects Donald Kellerman as Vice President, Clinical Development.
Dr. Kellerman most recently served as Senior Vice President of Clinical Development & Regulatory Affairs at Tonix Pharmaceuticals.
Previously, Dr. Kellerman served as Senior Vice President of Clinical Development & Medical Affairs at MAP Pharmaceuticals, Inc. (acquired by Allergan, Inc.) for five years.
Dr. Kellerman also has held the position of Senior Vice President of Development at Inspire Pharmaceuticals, Inc., where he was responsible for all aspects of drug development, including clinical research, regulatory affairs, project management and biostatistics.
He also led groups responsible for running several clinical programs in the respiratory, ophthalmology and cardiovascular areas. In addition, Dr. Kellerman has served in various clinical and project leadership positions at Glaxo Wellcome, Sepracor, Inc., and E.R. Squibb and Sons, Inc.
He has more than 25 years of experience in the development of prescription pharmaceuticals and has lead- or co-authored more than 80 publications. Dr. Kellerman holds Doctor of Pharmacy and Bachelor of Science degrees from the College of Pharmacy at the University of Minnesota.
Zosano hires David Zhang as executive director, biostatistics and data management.
Dr. Zhang joins Zosano from Genentech, a member of the Roche Group. During his 13-year career at Genentech, Dr. Zhang worked in clinical development across all phases in multiple therapeutic areas and geographic regions.
Prior to joining Genentech, Dr. Zhang worked at Eli Lilly and Company and at Abbott Laboratories. His industry experience spans from biometrics, clinical development strategies, regulatory interactions and submissions, and clinical trial innovations to leading high-performing teams.
Dr. Zhang received his Ph.D. in Biostatistics from UCLA and post-doctoral training from Columbia University. He also holds an executive M.B.A. from Indiana University.
Jacquie Mardell joins Zosano as senior director, clinical operations.
Ms. Mardell joins Zosano after serving for more than a year as clinical operations consultant for Zosano. Ms. Mardell has previously held clinical operations director positions at Metabolex (now Cymabay), Corcept Therapeutics, Neuromed Pharmaceuticals, Roche and Syntex, in a wide variety of therapeutic areas, including osteoporosis, diabetes, cortisol-related psychiatric illness, HIV and CMV infection. ■